Abstract: This disclosure provides isolation for a medical amplifier by providing a low impedance path for noise across an isolation barrier. The low impedance path can include a capacitive coupling between a patient ground, which is isolated from control circuitry, and a functional ground of an isolation system that is isolated from earth ground. The low impedance path can draw noise current from an input of an amplifier of patient circuitry.

Abstract: This disclosure provides isolation for a medical amplifier by providing a low impedance path for noise across an isolation barrier. The low impedance path can include a capacitive coupling between a patient ground, which is isolated from control circuitry, and a functional ground of an isolation system that is isolated from earth ground. The low impedance path can draw noise current from an input of an amplifier of patient circuitry.

Abstract: This disclosure provides isolation for a medical amplifier by providing a low impedance path for noise across an isolation barrier. The low impedance path can include a capacitive coupling between a patient ground, which is isolated from control circuitry, and a functional ground of an isolation system that is isolated from earth ground. The low impedance path can draw noise current from an input of an amplifier of patient circuitry.

Abstract: This disclosure provides isolation for a medical amplifier by providing a low impedance path for noise across an isolation barrier. The low impedance path can include a capacitive coupling between a patient ground, which is isolated from control circuitry, and a functional ground of an isolation system that is isolated from earth ground. The low impedance path can draw noise current from an input of an amplifier of patient circuitry.

Abstract: Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I): where m, n, p, V, R1, R2, R3, R4, R5 and R6 are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.

Abstract: Novel compounds useful in the treatment of, prevention of or protection against diseases and/or conditions related to metabolic syndrome and lipid metabolism, especially diseases of fatty acid and cholesterol metabolism, such as those mediated by stearoyl-CoA desaturase, are disclosed along with methods of employing said compounds for such uses.

Abstract: The invention relates to certain bicyclic heterocycles havng the structure shown below which are useful in the treatment of diseases related to lipid and carbohydrate metabolism, such as type 2 diabetes, and atherosclerosis.

Abstract: The invention relates to certain bicyclic heterocycles havng the structure shown below which are useful in the treatment of diseases related to lipid and carbohydrate metabolism, such as type 2 diabetes, and atherosclerosis.

Abstract: A signal management system is disclosed which integrates a patient switching box and an amplification unit into a single compact enclosure sufficiently small to reside by the patient table in an operating unit set up for electrophysiology procedures. The system includes a front panel designed to accept standard ECG leads, a plurality of intracardiac leads, including leads available for stimulation and/or lesion generation, and a plurality of pressure channels. The front panel also includes a touch screen display to allow quick assignments of labels to each of the ECG or intracardiac leads and the pressure channels. The system includes an onboard microprocessor which allows any operation performed on the system to be automatically updated on a remote computer processing unit if attached, and vice-versa. Digital signal processors are used in the system to perform switching operations on the electrical signals received, and to perform gain, limiting and/or filtering processes thereon.

Abstract: This invention provides a computing device which calculates the total energy and total pairwise, central forces between selected pairs of interacting particles within a system. The device comprises (a) a means for generating both (i) a retrievable identifier for the spatial coordinates (x, y, z) of a particle i and (ii) retrievable identifiers of the type of pairwise, central interaction between i and a second particle j; (b) a means for determining r.sup.2, the square of the radius vector between i and j; (c) a means for determining r, the square root of r.sup.2 ; (d) a means for calculating energy and force/r values for each ij pair; (e) means for determining the force on each particle; and (f) means for accumulating energy and force/r values for each ij particle pair.